Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight...
According to the National Survey on Drug Use and Health conducted in 2015, 86.4% of people over the age of...
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
Drug-drug and drug-food interactions (DDIs) contribute to adverse drug events (ADEs) which can range in severity from mild effects to...
The United States is in an overdose epidemic, with the CDC estimating that 106,699 individuals died of a drug-involved overdose...
Neonatal abstinence syndrome (NAS) affects infants who were exposed to opioids or other substances while in the womb.1 NAS has...
Sign up for the Aegis Newsletter